Two brothers presented with olivopontocerebellar atrophy of neonatal onset. The clinical features (failure to thrive, hypotonia, liver disease, effusions, and visual inattention) were similar to those of the four cases already reported, as were the necropsy findings of olivopontocerebellar atrophy, hepatic steatosis and fibrosis, and microcystic renal changes. The clinical similarities between this and the disialotransferrin developmental deficiency syndrome were noted. The characteristic abnormality of serum transferrin found in the latter syndrome was also found in the two cases reported here. We suggest that both syndromes are caused by the same, or related, defects in glycoprotein metabolism.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1793023PMC
http://dx.doi.org/10.1136/adc.66.9.1027DOI Listing

Publication Analysis

Top Keywords

olivopontocerebellar atrophy
12
atrophy neonatal
8
neonatal onset
8
disialotransferrin developmental
8
developmental deficiency
8
deficiency syndrome
8
cases reported
8
onset disialotransferrin
4
syndrome brothers
4
brothers presented
4

Similar Publications

Article Synopsis
  • The inferior olive (IO) is a key brainstem region affected by spinocerebellar ataxias (SCAs), impacting motor learning, but its degeneration mechanisms remain unclear.
  • Researchers studied SCA1 using a genetically modified mouse model (SCA1-KI) and found that these mice show olivary hypertrophy similar to hypertrophic olivary degeneration (HOD), with early neuronal changes but no loss of cells.
  • The SCA1-KI IO neurons are hyperexcitable and have reduced expression of ion channels that typically regulate their activity, indicating a dysregulation linked to mutant ataxin-1 expression in these neurons.
View Article and Find Full Text PDF

Olivopontocerebellar degeneration (OPCD) primarily affects individuals in their mid to late adulthood, making its early onset in young adults, particularly postpartum women, a notable rarity. This case report describes OPCD in a 24-year-old female, underscoring the importance of considering neurodegenerative disorders in differential diagnoses even in younger patients. The unique presentation post childbirth adds to the sparse literature on the timing and triggers of neurodegenerative diseases in younger populations, especially in scenarios that might involve hormonal, vascular, or autoimmune shifts such as those occurring postpartum.

View Article and Find Full Text PDF

Atypical Parkinsonian Syndromes: Structural, Functional, and Molecular Imaging Features.

AJNR Am J Neuroradiol

December 2024

Neuroradiology Division (F.M., S.S., A.M.F.), Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, New York

Atypical parkinsonian syndromes, also known as Parkinson-plus syndromes, are a heterogeneous group of movement disorders, including dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), multisystem atrophy (MSA), and corticobasal degeneration (CBD). This review highlights the characteristic structural, functional, and molecular imaging features of these complex disorders. DLB typically demonstrates parieto-occipital hypometabolism with involvement of the cuneus on FDG-PET, whereas dopaminergic imaging, such as [I]-FP-CIT SPECT (DaTscan) or fluorodopa (FDOPA)-PET, can be utilized as an adjunct for diagnosis.

View Article and Find Full Text PDF
Article Synopsis
  • Pontocerebellar hypoplasia type 2a (PCH2a) is a rare genetic disorder affecting children, characterized by underdeveloped brain regions (cerebellum and pons) and progressive small head size (microcephaly).
  • The disorder is caused by a specific genetic variant in the TSEN54 gene, which impacts a key protein involved in RNA processing, but the underlying mechanisms of the disease are not well understood.
  • Researchers created human models of PCH2a using stem cells to study the disease, finding that cerebellar organoids from affected individuals were smaller and showed altered cell growth patterns, suggesting a developmental issue in the brain as part of the disease's
View Article and Find Full Text PDF

A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.

Brain Behav Immun

October 2024

Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Translational Neuroscience Research Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, Fukuoka, Japan; Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Fukuoka, Japan. Electronic address:

Multiple system atrophy (MSA) is a severe α-synucleinopathy facilitated by glial reactions; the cerebellar variant (MSA-C) preferentially involves olivopontocerebellar fibres with conspicuous demyelination. A lack of aggressive models that preferentially involve olivopontocerebellar tracts in adulthood has hindered our understanding of the mechanisms of demyelination and neuroaxonal loss, and thus the development of effective treatments for MSA. We therefore aimed to develop a rapidly progressive mouse model that recaptures MSA-C pathology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!